Biohit Oyj (HEL:BIOBV)

Biohit Oyj Statistics

Total Valuation

Biohit Oyj has a market cap or net worth of EUR 46.81 million. The enterprise value is 43.01 million.

Market Cap	46.81M
Enterprise Value	43.01M

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Biohit Oyj has 15.20 million shares outstanding. The number of shares has increased by 0.50% in one year.

Current Share Class	12.22M
Shares Outstanding	15.20M
Shares Change (YoY)	+0.50%
Shares Change (QoQ)	-0.68%
Owned by Insiders (%)	19.73%
Owned by Institutions (%)	0.59%
Float	7.10M

Valuation Ratios

The trailing PE ratio is 20.62.

PE Ratio	20.62
Forward PE	n/a
PS Ratio	3.28
PB Ratio	3.57
P/TBV Ratio	3.74
P/FCF Ratio	121.90
P/OCF Ratio	59.55
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.37, with an EV/FCF ratio of 112.00.

EV / Earnings	18.96
EV / Sales	3.01
EV / EBITDA	15.37
EV / EBIT	17.50
EV / FCF	112.00

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 0.11.

Current Ratio	2.80
Quick Ratio	2.51
Debt / Equity	0.11
Debt / EBITDA	0.50
Debt / FCF	3.65
Interest Coverage	8.19

Financial Efficiency

Return on equity (ROE) is 18.98% and return on invested capital (ROIC) is 11.81%.

Return on Equity (ROE)	18.98%
Return on Assets (ROA)	9.63%
Return on Invested Capital (ROIC)	11.81%
Return on Capital Employed (ROCE)	17.30%
Revenue Per Employee	291,490
Profits Per Employee	46,286
Employee Count	46
Asset Turnover	0.90
Inventory Turnover	4.64

Taxes

In the past 12 months, Biohit Oyj has paid 299,000 in taxes.

Income Tax	299,000
Effective Tax Rate	11.65%

Stock Price Statistics

The stock price has increased by +27.05% in the last 52 weeks. The beta is 0.70, so Biohit Oyj's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+27.05%
50-Day Moving Average	2.90
200-Day Moving Average	2.87
Relative Strength Index (RSI)	53.95
Average Volume (20 Days)	8,556

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biohit Oyj had revenue of EUR 14.28 million and earned 2.27 million in profits. Earnings per share was 0.15.

Revenue	14.28M
Gross Profit	9.64M
Operating Income	2.46M
Pretax Income	2.57M
Net Income	2.27M
EBITDA	2.52M
EBIT	2.46M
Earnings Per Share (EPS)	0.15

Balance Sheet

The company has 5.20 million in cash and 1.40 million in debt, giving a net cash position of 3.80 million or 0.25 per share.

Cash & Cash Equivalents	5.20M
Total Debt	1.40M
Net Cash	3.80M
Net Cash Per Share	0.25
Equity (Book Value)	13.10M
Book Value Per Share	0.86
Working Capital	6.30M

Cash Flow

In the last 12 months, operating cash flow was 786,000 and capital expenditures -402,000, giving a free cash flow of 384,000.

Operating Cash Flow	786,000
Capital Expenditures	-402,000
Free Cash Flow	384,000
FCF Per Share	0.03

Margins

Gross margin is 67.49%, with operating and profit margins of 17.20% and 15.88%.

Gross Margin	67.49%
Operating Margin	17.20%
Pretax Margin	17.97%
Profit Margin	15.88%
EBITDA Margin	17.64%
EBIT Margin	17.20%
FCF Margin	2.69%

Dividends & Yields

Biohit Oyj does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.50%
Shareholder Yield	-0.50%
Earnings Yield	4.85%
FCF Yield	0.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biohit Oyj has an Altman Z-Score of 7.32 and a Piotroski F-Score of 4.

Altman Z-Score	7.32
Piotroski F-Score	4